Ocular Therapeutix Inc Live Stock Price Today, Share Analysis and Chart

Name: Ocular Therapeutix Inc: Is Infosys Ltd. worth buying?
Item: Ocular Therapeutix Inc
Rating: 1.196388875
Author: Trendlyne DVM scores

Momentum Trap

about

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of e...

11.27 -0.01 (-0.09%)

31.45% Fall from 52W High

6.6M

XNAS Volume

High vol. this week

XNAS 16 Jan, 2026 4:30 PM (EST)

Low Financial Strength

22.2 / 100

Expensive Valuation

6.7 / 100

Technically Neutral

44.6 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 114%

12 analysts

Ocular Therapeutix Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ocular Therapeutix Inc Live Stock Price Today, Share Analysis and Chart

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of e...

31.45% Fall from 52W High

High vol. this week

SWOT Analysis

Ocular Therapeutix Inc Live Price Chart